期刊文献+

颗粒溶素活性肽与增强型绿色荧光蛋白融合基因真核表达质粒的构建及其在小鼠黑色素瘤细胞中的表达 被引量:2

Construction of Eukaryotic Expression Vector for Fusion Gene of Granulysin Active Peptide 9ku-GLS and Enhanced Green Fluorescent Protein and Its Expression in Murine Melanoma B16 Cells
下载PDF
导出
摘要 目的构建人颗粒溶素(GLS)活性肽(9ku-GLS)与增强型绿色荧光蛋白(EGFP)融合基因的真核表达载体,并检测其在小鼠黑色素瘤细胞B16中的表达。方法经PCR扩增9ku-GLS基因,插入质粒pBudCE4.1中,经酶切及测序鉴定正确后,亚克隆至质粒pEGFP-C1中,将融合基因真核表达质粒pEGFP-C1/S9K转染B16细胞,采用荧光显微镜及RT-PCR法检测融合蛋白的表达。结果融合基因真核表达质粒pEGFP-C1/S9K经双酶切鉴定证明构建正确,转染B16细胞24h后,荧光显微镜下可观察到绿色荧光,且经RT-PCR可扩增出267bp的目的基因片段。结论已成功构建9ku-GLS与EGFP融合基因的真核表达质粒,且在B16细胞中表达了融合蛋白。 Objective To construct a eukaryotic expression vector for fusion gene of granulysin active peptide (9ku-GLS) and enhanced green fluorescent protein (EGFP) and observe its expression in murine melanoma B16 cells. Methods 9ku-GLS gene was amplified by PCR and insert into plasmid pBudCE4.1. The constructed recombinant plasmid pBudCE4.1/S9K was identified by restriction analysis and sequencing and subcloned to plasmid pEGFP-C1. B16 cells were transfected with the constructed recombinant plasmid pEGFP-C1/S9K and the expressed fusion protein was identified by fluorescent microscopy and RT-PCR. Results Restriction analysis proved that recombinant plasmid pEGFP-C1/S9K was constructed correctly. Green fluorescence was observed in the B16 cells 24 h after transfection with pEGFP-CI / S9K, and the target gene fragment at a length of 267 bp was amplified by RT-PCR. Conclusion The eukaryotic expression vector for fusion gene of 9ku-GLS and EGFP was successfully constructed and expressed in B16 cells.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第12期1043-1046,共4页 Chinese Journal of Biologicals
基金 国家自然科学基金(30400375) 重庆市自然科学基金(CSTC 2006BB5273)
关键词 颗粒溶素 增强型绿色荧光蛋白 融合基因 真核表达 黑色素瘤细胞 Granulysin (GIS) Enhanced green fluorescent protein (EGFP) Fusion gene Eukaryotic expression Melanoma cells
  • 相关文献

参考文献11

  • 1Huang LP, Lyu SC, Clayberger C, et al. Granulysin-mediated tumor rejection in transgenic mice. J Immunol, 2007, 178 ( 1 ): 77-84.
  • 2Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science, 1998, 282 (5386): 121-125.
  • 3Clayberger C, Krensky AM. Granulysin. Curr Opin Immunol, 2003, 15(5): 560- 565.
  • 4Ogawa K, Takamori Y, Suzuki K, et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol, 2003, 33 (7): 1925-1933.
  • 5Saigusa S, Ichikura T, Tsujimoto H, et al. Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma. J Gastroenterol Hepatol, 2007, 22(8): 1322-1327.
  • 6Pena SV, Krensky AM. Granulysin, a new human cytolytic granuleassociated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol, 1997, 9(2): 117-125.
  • 7Pena SV, Hanson DA, Carr BA, et al. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol, 1997, 158(6): 2680-2688.
  • 8Sekiya M, Ohwada A, Katae M, et al. Adenovirus vector-mediated transfer of 9 kDa granulysin induces DNA fragmentation in HuD antigen-expressing small cell lung cancer murine model ceils. Respirology, 2002, 7( 1 ): 29-35.
  • 9Hanson DA, Ziegler SF. Fusion of green fluorescent protein to the C-terminus of granulysin alters its intracellular localization in comparison to the native molecule. J Negat Results Biomed, 2004, 3 (1): 2.
  • 10伊正君,朱道银,李俊明,何永林,杨健,李娜.人颗粒溶素与EGFP基因融合表达载体的构建及其在鼠巨噬细胞RAW264.7中的表达[J].第四军医大学学报,2005,26(23):2125-2128. 被引量:3

二级参考文献6

  • 1Ogawa K, Takamori Y, Suzuki K, et al. Granulysin in human serum as a marker of cell-mediated immunity [ J ]. Eur J Immunol, 2003;33(7) :1925 - 1933.
  • 2Kida Y, Shimizu T, Kuwano K. Opposing roles of activator protein1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line,THP-1[J]. Immunology, 2002; 107(4) :507 -516.
  • 3Hanson DA, Kaspar AA, Poulain FR, et al. Biosynthesis of granulysin, a novel cytolytic molecule[J]. Mol Immunol, 1999; 36(7):413 -422.
  • 4Hanson DA, Ziegler SF. Fusion of green fluorescent protein to the C-terminus of granulysin alters its intracellular localization in comparison to the native molecule [J]. J Negat Results Biomed, 2004;3(1):2.
  • 5骆旭东,朱道银,陈全,蒋英,江山.结核分枝杆菌Ag85B和MPT64基因疫苗的免疫原性比较[J].第四军医大学学报,2003,24(17):1630-1631. 被引量:6
  • 6江山,朱道银,蒋英,骆旭东,陈全.结核分枝杆菌Ag85B-Ag85A双抗原融合真核表达质粒的构建及表达[J].第四军医大学学报,2003,24(21):1973-1975. 被引量:13

共引文献2

同被引文献13

  • 1仕瑶慧,樊建勇,杨慧兰.潜伏相关转录体在单纯疱疹病毒中的作用[J].国际皮肤性病学杂志,2006,32(5):324-326. 被引量:5
  • 2Kent JR, Kang W, Miller CG, et al. Herpes simplex virus latencyassociated transcript gene function [J]. J Neurovirol, 2003, 9 (3): 285-290.
  • 3Jin L, Carpenter D, Moerdyk-Schauwecker M, et al. Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice [J]. J Neurovirul, 2008, 14 (5): 389-400.
  • 4Carpenter D, Henderson G, Hsiang C, et al. Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity [J]. Microb Pathog, 2008, 44 (2): 98-102.
  • 5Branco FJ, Fraser NW. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis [J]. J Virol, 2005, 79 (14): 9019-9025.
  • 6Derfuss T, Arbusow V, Strupp M, et al. The presence of lytic HSV- 1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia [J]. Ann N Y Acad Sci, 2009, 1164: 300-304.
  • 7Shen W, Sa e Silva M, Jaber T, et al. Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis [J]. J Virol, 2009, 83 (18): 9131- 9139.
  • 8Daly CJ, McGrath JC. Fluorescent ligands, antibodies, and proteins for the study of receptors [J]. Pharmacol Ther, 2003, 100 (2): 101-118.
  • 9Li B X, Ge J W,Li Y J. Porcine aminopeptidase N is a function- al receptor for the PEDV coronavirus[J]. Virology, 2007,365 (1) =166-172.
  • 10Straw B E,Zimmerman J J,IAllaire S,et al. Diseases of swine IMp. Oxford = Blaekwell Publishing Ltd, 2006.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部